These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 88218)

  • 1. Differential effect of clofibrate on inflammation-induced alterations in plasma proteins in the rat.
    Powanda MC; Abeles FB; Bostian KA; Fowler JP; Hauer EC
    Biochem J; 1979 Mar; 178(3):633-41. PubMed ID: 88218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofibrate-induced alterations in zinc, iron and copper metabolism.
    Powanda MC; Blackburn BS; Bostian KA; Fowler JP; Hauer EC; Pekarek RS
    Biochem Pharmacol; 1978 Jan; 27(1):125-7. PubMed ID: 74255
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of hypolipidemic drug clofibrate in altering iron regulatory proteins IRP1 and IRP2 activities and hepatic iron metabolism in rats fed a low-iron diet.
    Huang HL; Shaw NS
    Toxicol Appl Pharmacol; 2002 Apr; 180(2):118-28. PubMed ID: 11969379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofibrate hypocholesterolemia associated with increased hepatic copper.
    Klevay LM
    Drug Nutr Interact; 1983; 2(2):131-7. PubMed ID: 6678750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and turnover of prothrombin during experimental inflammation in rats.
    Koj A; Regoeczi E; Chindemi PA; Gauldie J
    Br J Exp Pathol; 1984 Dec; 65(6):691-700. PubMed ID: 6208926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Messenger RNA activities of four acute phase proteins during inflammation.
    Northemann W; Andus T; Gross V; Nagashima M; Schreiber G; Heinrich PC
    FEBS Lett; 1983 Sep; 161(2):319-22. PubMed ID: 6194014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of acute-phase synthesis of fibrinogen by a hypolipidemic drug (clofibrate).
    Pickart L
    Int J Tissue React; 1981 Jun; 3(2):65-72. PubMed ID: 7327616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids and catecholamines as mediators of acute-phase proteins, especially rat alpha-macrofoetoprotein.
    van Gool J; Boers W; Sala M; Ladiges NC
    Biochem J; 1984 May; 220(1):125-32. PubMed ID: 6204643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma iron, serum copper, and serum zinc during therapy with ovulation inhibitors (author's transl)].
    Heinemann G
    Med Klin; 1974 May; 69(20):892-6. PubMed ID: 4849408
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute phase response in the horse: plasma protein changes associated with adjuvant induced inflammation.
    Patterson SD; Auer D; Bell K
    Biochem Int; 1988 Aug; 17(2):257-64. PubMed ID: 3142478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper and zinc status during acute inflammation: studies on blood, liver and kidneys metal levels in normal and inflamed rats.
    Milanino R; Cassini A; Conforti A; Franco L; Marrella M; Moretti U; Velo GP
    Agents Actions; 1986 Nov; 19(3-4):215-23. PubMed ID: 3825742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of the level of proteinase inhibitors in rat plasma during turpentine-induced inflammation.
    Warwas M; Osada J
    Experientia; 1985 May; 41(5):633-4. PubMed ID: 2581802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnitude of the acute phase protein response is attenuated by protein deficiency in rats.
    Jennings G; Bourgeois C; Elia M
    J Nutr; 1992 Jun; 122(6):1325-31. PubMed ID: 1375288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host metabolic alterations during Venezuelan equine encephalitis in the rat.
    Neufeld HA; Powanda MC; DePaoli A; Pace JA; Jahrling PB
    J Lab Clin Med; 1978 Feb; 91(2):255-63. PubMed ID: 621426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of D-galactosamine on plasma protein synthesis by the perfused rat liver from turpentine-stimulated donors.
    Koj A; Dubin A
    Br J Exp Pathol; 1978 Oct; 59(5):504-13. PubMed ID: 718802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine oxidation and protein turnover in clofibrate-induced muscle protein degradation in rats.
    Paul HS; Adibi SA
    J Clin Invest; 1980 Jun; 65(6):1285-93. PubMed ID: 7410544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor-associated hyperfibrinogenemia and free fatty acidemia with p-phenoxybenzalbutyrate (clofibrate).
    Pickart L; Thaler MM
    Cancer Res; 1979 Oct; 39(10):3845-8. PubMed ID: 476620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver.
    Ishiguro H; Katano Y; Nakano I; Ishigami M; Hayashi K; Honda T; Goto H; Bajotto G; Maeda K; Shimomura Y
    Life Sci; 2006 Jul; 79(8):737-43. PubMed ID: 16616211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of serum zinc and copper to inflammatory stimulation in the rat with chronic liver damage.
    Garduño Espinosa J; Paniagua Sierra R; Díaz Bensussen S; Lifshitz A
    Arch Invest Med (Mex); 1991; 22(3-4):289-94. PubMed ID: 1844115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inflammation on iron and transferrin metabolism.
    O'Shea MJ; Kershenobich D; Tavill AS
    Br J Haematol; 1973 Dec; 25(6):707-14. PubMed ID: 4760500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.